• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

岩藻依聚糖可抑制活动性海曼肾炎蛋白尿的发展。

Fucoidan inhibits the development of proteinuria in active Heymann nephritis.

作者信息

Zhang Quanbin, Li Ning, Zhao Tingting, Qi Huimin, Xu Zuhong, Li Zhien

机构信息

Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, P.R. China.

出版信息

Phytother Res. 2005 Jan;19(1):50-3. doi: 10.1002/ptr.1623.

DOI:10.1002/ptr.1623
PMID:15799003
Abstract

Fucoidan, the sulphated polysaccharide extracted from brown seaweed, has various biological activities. The effect of fucoidan on the formation of proteinuria and renal functions in active Heymann nephritis was investigated in this study. Active Heymann nephritis was induced by administering brush border protein of rat proximal uriniferous tubules (FX1A). Fucoidan was administered by oral intubation to Heymann nephritis rats at three doses (50, 100 and 200 mg/kg) once daily for 4 weeks. The elevated urinary protein excretion and plasma creatinine due to the induction of Heymann nephritis were significantly reduced by fucoidan at doses of 100 and 200 mg/kg. The results indicated that fucoidan has a renoprotective effect on active Heymann nephritis and is a promising therapeutic agent for nephritis.

摘要

岩藻多糖是从褐藻中提取的硫酸化多糖,具有多种生物活性。本研究探讨了岩藻多糖对活动性海曼肾炎蛋白尿形成及肾功能的影响。通过给予大鼠近端肾小管刷状缘蛋白(FX1A)诱导活动性海曼肾炎。将岩藻多糖以三种剂量(50、100和200mg/kg)经口插管给予海曼肾炎大鼠,每日一次,持续4周。100和200mg/kg剂量的岩藻多糖显著降低了因诱导海曼肾炎而升高的尿蛋白排泄和血浆肌酐。结果表明,岩藻多糖对活动性海曼肾炎具有肾脏保护作用,是一种有前景的肾炎治疗药物。

相似文献

1
Fucoidan inhibits the development of proteinuria in active Heymann nephritis.岩藻依聚糖可抑制活动性海曼肾炎蛋白尿的发展。
Phytother Res. 2005 Jan;19(1):50-3. doi: 10.1002/ptr.1623.
2
Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.由抗肾小管刷状缘糖蛋白gp108的异源抗体诱导的伴有急性和严重蛋白尿的被动性海曼肾炎。
Lab Invest. 1986 Jul;55(1):63-70.
3
Effects of fucoidan on chronic renal failure in rats.岩藻依聚糖对大鼠慢性肾衰竭的影响。
Planta Med. 2003 Jun;69(6):537-41. doi: 10.1055/s-2003-40634.
4
Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.抗gp330自身抗体的表位特异性决定了活动性海曼肾炎中蛋白尿的发展。
Am J Pathol. 1993 Mar;142(3):821-9.
5
Effect and mechanism of fucoidan derivatives from Laminaria japonica in experimental adenine-induced chronic kidney disease.褐藻糖胶衍生物对实验性腺嘌呤诱导的慢性肾脏病的作用及机制。
J Ethnopharmacol. 2012 Feb 15;139(3):807-13. doi: 10.1016/j.jep.2011.12.022. Epub 2011 Dec 22.
6
Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.抗糖脂抗体激活补体并促进被动型海曼肾炎中的蛋白尿。
Am J Pathol. 1994 Apr;144(4):807-19.
7
Heymann nephritis in Lewis rats.刘易斯大鼠的海曼肾炎
Curr Protoc Immunol. 2015 Apr 1;109:15.29.1-15.29.6. doi: 10.1002/0471142735.im1529s109.
8
Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells.白细胞介素-4疗法通过抑制Tc1细胞来预防活动性海曼肾炎中蛋白尿的发展。
J Immunol. 2001 Oct 1;167(7):3725-33. doi: 10.4049/jimmunol.167.7.3725.
9
A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.海曼肾炎的一种主要致病抗原仅存在于肾近端小管刷状缘——用抗链霉蛋白酶消化的肾小管抗原的单克隆抗体进行的研究。
Clin Exp Immunol. 1994 May;96(2):303-10. doi: 10.1111/j.1365-2249.1994.tb06558.x.
10
Suppression of experimental membranous glomerulonephritis in rats by an anti-MHC class II antibody.抗MHC II类抗体对大鼠实验性膜性肾小球肾炎的抑制作用
Nephron. 2001 Jul;88(3):233-40. doi: 10.1159/000045995.

引用本文的文献

1
Comparative Study of Fucoidan from and Its Depolymerized Fragment on Adriamycin-Induced Nephrotic Syndrome in Rats.褐藻糖胶及其解聚片段对阿霉素肾病大鼠模型的比较研究。
Mar Drugs. 2020 Feb 27;18(3):137. doi: 10.3390/md18030137.
2
Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy.岩藻依聚糖通过上调蛋白激酶A来提高尿酸肾病中有机阳离子转运体2的表达。
Exp Ther Med. 2017 Nov;14(5):4153-4159. doi: 10.3892/etm.2017.5077. Epub 2017 Aug 30.
3
The Structure and Nephroprotective Activity of Oligo-Porphyran on Glycerol-Induced Acute Renal Failure in Rats.
寡聚紫菜多糖对甘油诱导的大鼠急性肾衰竭的结构及肾保护活性
Mar Drugs. 2017 May 9;15(5):135. doi: 10.3390/md15050135.
4
Oligo-fucoidan prevents renal tubulointerstitial fibrosis by inhibiting the CD44 signal pathway.寡聚岩藻聚糖通过抑制 CD44 信号通路来预防肾间质纤维化。
Sci Rep. 2017 Jan 18;7:40183. doi: 10.1038/srep40183.
5
Toxicological Evaluation of Low Molecular Weight Fucoidan in Vitro and in Vivo.低分子量岩藻依聚糖的体内外毒理学评价
Mar Drugs. 2016 Jun 24;14(7):121. doi: 10.3390/md14070121.
6
Marine polysaccharides from algae with potential biomedical applications.具有潜在生物医学应用价值的藻类海洋多糖。
Mar Drugs. 2015 May 15;13(5):2967-3028. doi: 10.3390/md13052967.
7
The protective effect of fucoidan in rats with streptozotocin-induced diabetic nephropathy.岩藻依聚糖对链脲佐菌素诱导的糖尿病肾病大鼠的保护作用。
Mar Drugs. 2014 May 30;12(6):3292-306. doi: 10.3390/md12063292.
8
Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds.影响岩藻聚糖硫酸酯生物活性的重要因素:褐藻中含岩藻糖的硫酸多糖结构-功能关系及提取方法的批判性综述
Mar Drugs. 2011;9(10):2106-2130. doi: 10.3390/md9102106. Epub 2011 Oct 24.
9
Therapies from fucoidan; multifunctional marine polymers.岩藻聚糖硫酸酯的疗法;多功能海洋聚合物。
Mar Drugs. 2011;9(10):1731-1760. doi: 10.3390/md9101731. Epub 2011 Sep 30.
10
Fucoidan: structure and bioactivity.岩藻依聚糖:结构与生物活性。
Molecules. 2008 Aug 12;13(8):1671-95. doi: 10.3390/molecules13081671.